Genenta Science SPA
GNTA
View Detailed Chart
1.450USD
-0.030-2.03%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
27.76MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-2.03%
5 Days
+2.84%
1 Month
-16.67%
6 Months
-52.61%
Year to Date
-66.67%
1 Year
-71.06%
View Detailed Chart
TradingKey Stock Score of Genenta Science SPA
Currency: USD Updated: 2025-10-27Key Insights
Its valuation is considered fairly valued, Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at max_target_price.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Genenta Science SPA's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
1
analysts
Buy
Current Rating
21.000
Target Price
+543.15%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Genenta Science SPA Highlights
StrengthsRisks
Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.
Overvalued
The company’s latest PE is -7.05, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 1.96M shares, decreasing 10.49% quarter-over-quarter.
Genenta Science SPA News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Genenta Science SPA Info
Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.
Ticker SymbolGNTA
CompanyGenenta Science SPA
CEOParacchi (Pierluigi)
Websitehttps://www.genenta.com/
FAQs
What is the current price of Genenta Science SPA (GNTA)?
The current price of Genenta Science SPA (GNTA) is 1.450.
What is the symbol of Genenta Science SPA?
The ticker symbol of Genenta Science SPA is GNTA.
What is the 52-week high of Genenta Science SPA?
The 52-week high of Genenta Science SPA is 10.000.
What is the 52-week low of Genenta Science SPA?
The 52-week low of Genenta Science SPA is 1.280.
What is the market capitalization of Genenta Science SPA?
The market capitalization of Genenta Science SPA is 27.76M.
What is the net income of Genenta Science SPA?
The net income of Genenta Science SPA is -8.91M.
Is Genenta Science SPA (GNTA) currently rated as Buy, Hold, or Sell?
According to analysts, Genenta Science SPA (GNTA) has an overall rating of Buy, with a price target of 21.000.
What is the Earnings Per Share (EPS TTM) of Genenta Science SPA (GNTA)?
The Earnings Per Share (EPS TTM) of Genenta Science SPA (GNTA) is -0.471.
Related Instruments
+1.32%
-0.88%
+1.75%
+0.83%
+0.60%
+0.38%
+0.91%
+1.03%
+2.32%
+0.60%
+0.40%
+1.97%
+1.63%
+1.21%
+0.65%
+0.66%
+2.57%
0.00%
-0.44%
+1.06%
